CELCUITY INC. (CELC) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 48.93M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 48.93M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 48.93M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 48.93M | (m) | (m) |
| 2026-03-31 | 48.77M | (m) | (m) |
| 2025-09-30 | 46.27M | (m) | (m) |
| 2025-06-30 | 42.43M | (m) | (m) |
| 2025-03-31 | 37.87M | (m) | (m) |
| 2024-12-31 | 37.84M | (m) | (m) |
| 2024-09-30 | 37.13M | (m) | (m) |
| 2024-06-30 | 37.03M | (m) | (m) |
| 2024-03-31 | 31.23M | (m) | (m) |
| 2023-09-30 | 24.20M | (m) | (m) |
| 2023-06-30 | 22.09M | (m) | (m) |
| 2023-03-31 | 21.96M | (m) | (m) |
| 2022-12-31 | 21.69M | (m) | (m) |
| 2022-09-30 | 15.46M | (m) | (m) |
| 2022-06-30 | 14.94M | (m) | (m) |
| 2022-03-31 | 14.94M | (m) | (m) |
| 2021-12-31 | 14.92M | (m) | (m) |
| 2021-09-30 | 14.91M | (m) | (m) |
| 2021-06-30 | 14.90M | (m) | (m) |
| 2021-03-31 | 12.65M | (m) | (m) |
| 2020-12-31 | 10.30M | (m) | (m) |
| 2020-09-30 | 10.30M | (m) | (m) |
| 2020-06-30 | 10.29M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |